Literature DB >> 27001159

Segmental allergen challenge increases levels of airway follistatin-like 1 in patients with asthma.

Marina Miller1, Stephane Esnault2, Richard C Kurten3, Elizabeth A Kelly2, Andrew Beppu1, Sudipta Das1, Peter Rosenthal1, Joe Ramsdell1, Michael Croft4, Bruce Zuraw1, Nizar Jarjour2, Qutayba Hamid5, David H Broide6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27001159      PMCID： PMC4975994          DOI： 10.1016/j.jaci.2016.01.019

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages.

Authors:  Joseph G Graham; Laura J MacDonald; S Kauser Hussain; Uma M Sharma; Richard C Kurten; Daniel E Voth
Journal:  Cell Microbiol       Date:  2013-01-14       Impact factor: 3.715

2.  Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice.

Authors:  Dae Hyun Lim; Jae Youn Cho; Marina Miller; Kirsti McElwain; Shauna McElwain; David H Broide
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-08       Impact factor: 5.464

3.  Fstl1 Promotes Asthmatic Airway Remodeling by Inducing Oncostatin M.

Authors:  Marina Miller; Andrew Beppu; Peter Rosenthal; Alexa Pham; Sudipta Das; Maya Karta; Dae Jin Song; Christine Vuong; Taylor Doherty; Michael Croft; Bruce Zuraw; Xu Zhang; Xiang Gao; Seema Aceves; Fazila Chouiali; Qutayba Hamid; David H Broide
Journal:  J Immunol       Date:  2015-09-09       Impact factor: 5.422

4.  Increased matrix metalloproteinase-9 in the airway after allergen challenge.

Authors:  E A Kelly; W W Busse; N N Jarjour
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

5.  Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation.

Authors:  Didier D Cataldo; Kurt G Tournoy; Karim Vermaelen; Carine Munaut; Jean-Michel Foidart; Renaud Louis; Agnès Noël; Romain A Pauwels
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  Segmental allergen challenge enhances chitinase activity and levels of CCL18 in mild atopic asthma.

Authors:  M L Gavala; E A B Kelly; S Esnault; S Kukreja; M D Evans; P J Bertics; G L Chupp; N N Jarjour
Journal:  Clin Exp Allergy       Date:  2013-02       Impact factor: 5.018

Review 7.  Follistatin-like 1 in vertebrate development.

Authors:  M Sylva; A F M Moorman; M J B van den Hoff
Journal:  Birth Defects Res C Embryo Today       Date:  2013-03

Review 8.  Immunologic and inflammatory mechanisms that drive asthma progression to remodeling.

Authors:  David H Broide
Journal:  J Allergy Clin Immunol       Date:  2008-03       Impact factor: 10.793

Review 9.  Follistatin-like protein 1 and its role in inflammation and inflammatory diseases.

Authors:  Yury Chaly; Bruce Hostager; Sonja Smith; Raphael Hirsch
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829
  9 in total
  8 in total

Review 1.  The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease.

Authors:  Kathryn L Pothoven; Robert P Schleimer
Journal:  Tissue Barriers       Date:  2017-06-13

2.  GSDMB induces an asthma phenotype characterized by increased airway responsiveness and remodeling without lung inflammation.

Authors:  Sudipta Das; Marina Miller; Andrew K Beppu; James Mueller; Matthew D McGeough; Christine Vuong; Maya R Karta; Peter Rosenthal; Fazila Chouiali; Taylor A Doherty; Richard C Kurten; Qutayba Hamid; Hal M Hoffman; David H Broide
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

3.  Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease.

Authors:  Kathryn L Pothoven; James E Norton; Lydia A Suh; Roderick G Carter; Kathleen E Harris; Assel Biyasheva; Kevin Welch; Stephanie Shintani-Smith; David B Conley; Mark C Liu; Atsushi Kato; Pedro C Avila; Qutayba Hamid; Leslie C Grammer; Anju T Peters; Robert C Kern; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2016-12-18       Impact factor: 10.793

4.  Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling.

Authors:  Yanlong Zhu; Stephane Esnault; Nizar N Jarjour; Allan R Brasier; Ying Ge
Journal:  Clin Proteomics       Date:  2022-05-19       Impact factor: 5.000

5.  FSTL-1 Attenuation Causes Spontaneous Smoke-Resistant Pulmonary Emphysema.

Authors:  Matthew Henkel; Jessica Partyka; Alyssa D Gregory; Erick Forno; Michael H Cho; Taylor Eddens; Andrew R Tout; Nathan Salamacha; William Horne; Krithika S Rao; Yijen Wu; John F Alcorn; Dennis Kostka; Raphael Hirsch; Juan C Celedón; Steven D Shapiro; Jay K Kolls; Brian T Campfield
Journal:  Am J Respir Crit Care Med       Date:  2020-04-15       Impact factor: 21.405

Review 6.  Follistatin-like 1 in development and human diseases.

Authors:  Andrea Mattiotti; Stuti Prakash; Phil Barnett; Maurice J B van den Hoff
Journal:  Cell Mol Life Sci       Date:  2018-03-29       Impact factor: 9.261

7.  FSTL-1: A New Player in the Prevention of Emphysema.

Authors:  Ross Vlahos
Journal:  Am J Respir Crit Care Med       Date:  2020-04-15       Impact factor: 21.405

8.  FSTL1 aggravates cigarette smoke-induced airway inflammation and airway remodeling by regulating autophagy.

Authors:  Ying Liu; Jiawei Xu; Tian Liu; Jinxiang Wu; Jiping Zhao; Junfei Wang; Minfang Zou; Lili Cao; Xiaofei Liu; Yun Pan; Siyuan Huang; Liang Dong
Journal:  BMC Pulm Med       Date:  2021-01-28       Impact factor: 3.317
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.